CFO’s “Buy‑the‑Dip” Move Signals Confidence Amid SeaStar’s 60% Slide
Insider CFO buy at SeaStar Medical: 750 shares at $3.27 amid a steep 60% slide—signals potential upside for a low‑valued critical‑care stock.
3 minutes to read
SEASTAR MEDICAL HOLDING CORP
SeaStar Medical’s Executive Surge: CEO and Directors Bulk‑Buy Shares in Bold Vote of Confidence Amid Volatile Market Conditions
SeaStar insiders, including CEO Eric Schlorff, are buying shares—showing strong confidence in the company’s medical‑device growth and potential upside.
3 minutes to read